Hermanski-Pudlak Syndrome
"Hermanski-Pudlak Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Syndrome characterized by the triad of oculocutaneous albinism (ALBINISM, OCULOCUTANEOUS); PLATELET STORAGE POOL DEFICIENCY; and lysosomal accumulation of ceroid lipofuscin.
| Descriptor ID |
D022861
|
| MeSH Number(s) |
C11.270.040.545.400 C15.378.100.100.515 C15.378.100.685.400 C15.378.140.735.400 C15.378.463.735.400 C16.320.099.515 C16.320.290.040.100.400 C16.320.565.100.102.100.400 C16.320.850.080.100.400 C17.800.621.440.102.100.400 C17.800.827.080.100.400 C18.452.648.100.102.100.400
|
| Concept/Terms |
Hermanski-Pudlak Syndrome- Hermanski-Pudlak Syndrome
- Hermanski Pudlak Syndrome
- Hermansky-Pudlak Syndrome
- Hermansky Pudlak Syndrome
|
Below are MeSH descriptors whose meaning is more general than "Hermanski-Pudlak Syndrome".
- Diseases [C]
- Eye Diseases [C11]
- Eye Diseases, Hereditary [C11.270]
- Albinism [C11.270.040]
- Albinism, Oculocutaneous [C11.270.040.545]
- Hermanski-Pudlak Syndrome [C11.270.040.545.400]
- Hemic and Lymphatic Diseases [C15]
- Hematologic Diseases [C15.378]
- Blood Coagulation Disorders [C15.378.100]
- Blood Coagulation Disorders, Inherited [C15.378.100.100]
- Hermanski-Pudlak Syndrome [C15.378.100.100.515]
- Platelet Storage Pool Deficiency [C15.378.100.685]
- Hermanski-Pudlak Syndrome [C15.378.100.685.400]
- Blood Platelet Disorders [C15.378.140]
- Platelet Storage Pool Deficiency [C15.378.140.735]
- Hermanski-Pudlak Syndrome [C15.378.140.735.400]
- Hemorrhagic Disorders [C15.378.463]
- Platelet Storage Pool Deficiency [C15.378.463.735]
- Hermanski-Pudlak Syndrome [C15.378.463.735.400]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
- Blood Coagulation Disorders, Inherited [C16.320.099]
- Hermanski-Pudlak Syndrome [C16.320.099.515]
- Eye Diseases, Hereditary [C16.320.290]
- Albinism [C16.320.290.040]
- Albinism, Oculocutaneous [C16.320.290.040.100]
- Hermanski-Pudlak Syndrome [C16.320.290.040.100.400]
- Metabolism, Inborn Errors [C16.320.565]
- Amino Acid Metabolism, Inborn Errors [C16.320.565.100]
- Albinism [C16.320.565.100.102]
- Albinism, Oculocutaneous [C16.320.565.100.102.100]
- Hermanski-Pudlak Syndrome [C16.320.565.100.102.100.400]
- Skin Diseases, Genetic [C16.320.850]
- Albinism [C16.320.850.080]
- Albinism, Oculocutaneous [C16.320.850.080.100]
- Hermanski-Pudlak Syndrome [C16.320.850.080.100.400]
- Skin and Connective Tissue Diseases [C17]
- Skin Diseases [C17.800]
- Pigmentation Disorders [C17.800.621]
- Hypopigmentation [C17.800.621.440]
- Albinism [C17.800.621.440.102]
- Albinism, Oculocutaneous [C17.800.621.440.102.100]
- Hermanski-Pudlak Syndrome [C17.800.621.440.102.100.400]
- Skin Diseases, Genetic [C17.800.827]
- Albinism [C17.800.827.080]
- Albinism, Oculocutaneous [C17.800.827.080.100]
- Hermanski-Pudlak Syndrome [C17.800.827.080.100.400]
- Nutritional and Metabolic Diseases [C18]
- Metabolic Diseases [C18.452]
- Metabolism, Inborn Errors [C18.452.648]
- Amino Acid Metabolism, Inborn Errors [C18.452.648.100]
- Albinism [C18.452.648.100.102]
- Albinism, Oculocutaneous [C18.452.648.100.102.100]
- Hermanski-Pudlak Syndrome [C18.452.648.100.102.100.400]
Below are MeSH descriptors whose meaning is more specific than "Hermanski-Pudlak Syndrome".
This graph shows the total number of publications written about "Hermanski-Pudlak Syndrome" by people in this website by year, and whether "Hermanski-Pudlak Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2019 | 2 | 0 | 2 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hermanski-Pudlak Syndrome" by people in Profiles.
-
Cuevas-Mora K, Roque W, Shaghaghi H, Gochuico BR, Rosas IO, Summer R, Romero F. Hermansky-Pudlak syndrome-2 alters mitochondrial homeostasis in the alveolar epithelium of the lung. Respir Res. 2021 Feb 08; 22(1):49.
-
Alberelli MA, Bacci M, Marchetti M, Ferrazzi P, Dragani A, Gamba S, Landolfi R, Falanga A, Lodigiani C, De Candia E. Rituximab for treatment of autoimmune acquired platelet function disorders: description of two cases of acquired Glanzmann thrombasthenia and one case of acquired delta storage pool disease. Br J Haematol. 2019 12; 187(5):e87-e91.
-
Summer R, Krishna R, Schriner D, Cuevas-Mora K, Sales D, Para R, Roman J, Nieweld C, Gochuico BR, Romero F. Matrix metalloproteinase activity in the lung is increased in Hermansky-Pudlak syndrome. Orphanet J Rare Dis. 2019 07 04; 14(1):162.
-
Mao GF, Goldfinger LE, Fan DC, Lambert MP, Jalagadugula G, Freishtat R, Rao AK. Dysregulation of PLDN (pallidin) is a mechanism for platelet dense granule deficiency in RUNX1 haplodeficiency. J Thromb Haemost. 2017 04; 15(4):792-801.
-
Vicary GW, Vergne Y, Santiago-Cornier A, Young LR, Roman J. Pulmonary Fibrosis in Hermansky-Pudlak Syndrome. Ann Am Thorac Soc. 2016 10; 13(10):1839-1846.
-
Meng R, Wu J, Harper DC, Wang Y, Kowalska MA, Abrams CS, Brass LF, Poncz M, Stalker TJ, Marks MS. Defective release of a granule and lysosome contents from platelets in mouse Hermansky-Pudlak syndrome models. Blood. 2015 Mar 05; 125(10):1623-32.